Tuesday, 14 February 2023

Understanding G6PD Deficiency in Newborns and the Importance of Universal Newborn Screening: A Closer Look at Trivitron's Neonatal G6PD Kit

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a hereditary condition that impacts the function of red blood cells. This condition results from a mutation in the G6PD gene, which is found on the X chromosome. Since males have only one X chromosome, they are more likely to develop G6PD deficiency than females.

Neonatal G6PD Kit for universal newborn screening designed by Trivitron Healthcare

Newborns who are diagnosed with G6PD deficiency may experience episodes of hemolysis, which is the breakdown of red blood cells. This can result in complications such as anemia, jaundice, and other related issues. The severity of the episodes may vary depending on the type of G6PD deficiency the newborn has, along with other factors like exposure to certain chemicals, foods, and medication.


Newborns may not show any symptoms of G6PD deficiency at birth, and the symptoms may appear after a triggering event. Common triggers for hemolysis in newborns with G6PD deficiency are exposure to fava beans, certain medications, and infections. A blood test is usually conducted to diagnose G6PD deficiency in newborns, and treatment may involve supportive care, like blood transfusions and phototherapy for managing jaundice, along with avoiding known triggers.


Universal newborn screening is recommended as a preventive measure for G6PD deficiency in newborns. A newborn screening kit, such as the Neonatal G6PD Kit designed by Trivitron, is used to diagnose the condition in a quick and accurate manner. This easy-to-use kit consists of reagents and control solutions that are used to test a small amount of blood from the newborn. The results are visually interpreted and can be obtained within a few minutes.


Trivitron is dedicated to providing high-quality medical devices and diagnostic products, including the Neonatal G6PD Kit, for healthcare providers and patients worldwide. The company has a strong focus on research and development to improve its products and create new technologies to enhance the diagnosis and treatment of medical conditions. Trivitron Healthcare also offers a range of other medical devices and diagnostic products, including laboratory equipment, imaging systems, and point-of-care diagnostic tests. With proper management and care, most newborns with G6PD deficiency can lead normal, healthy lives.



No comments:

Post a Comment